 Kaskela Law LLC announces that it is investigating Karyopharm Therapeutics Inc. Karyopharm or the Company NASDAQ: KPTI on behalf of the Companys stockholders. The investigation seeks to determine whether the members of Karyopharms board of directors breached their fiduciary duties to the Company and its stockholders. 